Hacker News
- Three FDA Advisers Resign over Agency’s Approval of Alzheimer’s Drug https://www.nytimes.com/2021/06/10/health/aduhelm-fda-resign-alzheimers.html 40 comments
Linking pages
- FDA Approval of Alzheimer's Drug Prioritizes Profit Over Public Health https://www.businessinsider.com/fda-approval-broken-new-alzheimers-drug-prioritize-profit-over-public-health-2021-6 207 comments
- That $56,000 Drug? Blame Medicare. - The New York Times https://www.nytimes.com/2021/08/20/business/drug-cost-medicare-alzheimers.html 124 comments
- Critical elements of leading Alzheimer’s study possibly fraudulent | Alzheimer's | The Guardian https://theguardian.com/society/2022/jul/23/alzheimers-study-fraudulent 17 comments
- House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval - The New York Times https://www.nytimes.com/2021/09/02/health/aduhelm-fda.html 3 comments
- Alzheimer's, Inc.: When a Hypothesis Becomes Too Big to Fail - Scientific American https://www.scientificamerican.com/article/alzheimers-inc-when-a-hypothesis-becomes-too-big-to-fail/ 2 comments
- Biogen's Alzheimer’s Drug Poses a Dilemma for the F.D.A. - The New York Times https://www.nytimes.com/2021/06/05/health/alzheimers-aducanumab-fda.html 2 comments
- New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA - The New York Times https://www.nytimes.com/2021/06/22/upshot/alzheimers-aduhelm-medicare-cost.html 2 comments
- In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug - The New York Times https://www.nytimes.com/2021/07/08/health/aduhelm-alzheimers-fda.html 1 comment
- How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved - The New York Times https://www.nytimes.com/2021/07/19/health/alzheimers-drug-aduhelm-fda.html 1 comment
- Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm - The New York Times https://www.nytimes.com/2024/01/31/business/biogen-alzheimers-aduhelm.html 1 comment
- F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works - The New York Times https://www.nytimes.com/2021/06/07/health/fda-approves-alzheimers-drug.html 0 comments
- F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works - The New York Times https://www.nytimes.com/2021/06/07/health/aduhelm-fda-alzheimers-drug.html 0 comments
Linked pages
- https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12213 4 comments
- House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval - The New York Times https://www.nytimes.com/2021/09/02/health/aduhelm-fda.html 3 comments
- FDA’s Decision to Approve New Treatment for Alzheimer’s Disease | FDA https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease 2 comments
- Biogen's Alzheimer’s Drug Poses a Dilemma for the F.D.A. - The New York Times https://www.nytimes.com/2021/06/05/health/alzheimers-aducanumab-fda.html 2 comments
- New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA - The New York Times https://www.nytimes.com/2021/06/22/upshot/alzheimers-aduhelm-medicare-cost.html 2 comments
- F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works - The New York Times https://www.nytimes.com/2021/06/07/health/aduhelm-fda-alzheimers-drug.html 0 comments
Related searches:
Search whole site: site:www.nytimes.com
Search title: Three F.D.A. Advisers Resign Over Approval of Alzheimer's Drug - The New York Times
See how to search.